LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 50

Search options

  1. Article ; Online: Beach chair position, general anesthesia and deliberated hypotension during shoulder surgery: a dangerous combination!

    Mazzon, D / Danelli, G / Poole, D / Marchini, C / Bianchin, C

    Minerva anestesiologica

    2009  Volume 75, Issue 5, Page(s) 281–282

    MeSH term(s) Anesthesia, General/adverse effects ; Brain Ischemia/etiology ; Brain Ischemia/physiopathology ; Cerebrovascular Circulation ; Humans ; Hypotension, Controlled/adverse effects ; Intraoperative Complications/etiology ; Intraoperative Complications/physiopathology ; Posture ; Shoulder/surgery
    Language English
    Publishing date 2009-05
    Publishing country Italy
    Document type Letter
    ZDB-ID 123584-9
    ISSN 1827-1596 ; 0026-4717 ; 0375-9393
    ISSN (online) 1827-1596
    ISSN 0026-4717 ; 0375-9393
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Conservation of the deadenylase activity of proteins of the Caf1 family in human.

    Bianchin, Claire / Mauxion, Fabienne / Sentis, Stéphanie / Séraphin, Bertrand / Corbo, Laura

    RNA (New York, N.Y.)

    2005  Volume 11, Issue 4, Page(s) 487–494

    Abstract: The yeast Pop2 protein, belonging to the eukaryotic Caf1 family, is required for mRNA deadenylation in vivo. It also catalyzes poly(A) degradation in vitro, even though this property has been questioned. Caf1 proteins are related to RNase D, a feature ... ...

    Abstract The yeast Pop2 protein, belonging to the eukaryotic Caf1 family, is required for mRNA deadenylation in vivo. It also catalyzes poly(A) degradation in vitro, even though this property has been questioned. Caf1 proteins are related to RNase D, a feature supported by the recently published structure of Pop2. Yeast Pop2 contains, however, a divergent active site while its human homologs harbor consensus catalytic residues. Given these differences, we tested whether its deadenylase activity is conserved in the human homologs Caf1 and Pop2. Our data demonstrate that both human factors degrade poly(A) tails indicating their involvement in mRNA metabolism.
    MeSH term(s) Amino Acid Sequence ; Conserved Sequence ; Escherichia coli/genetics ; Escherichia coli/metabolism ; Humans ; Molecular Sequence Data ; Poly A/metabolism ; Proteins/genetics ; Proteins/metabolism ; RNA Stability ; RNA, Messenger/metabolism ; Recombinant Proteins/metabolism ; Ribonucleases/metabolism ; Saccharomyces cerevisiae ; Saccharomyces cerevisiae Proteins/metabolism ; Sequence Alignment ; Transcription Factors
    Chemical Substances CNOT8 protein, human ; Proteins ; RNA, Messenger ; Recombinant Proteins ; Saccharomyces cerevisiae Proteins ; Transcription Factors ; Poly A (24937-83-5) ; Ribonucleases (EC 3.1.-) ; POP2 protein, S cerevisiae (EC 3.1.13.4)
    Language English
    Publishing date 2005-04
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1241540-6
    ISSN 1355-8382
    ISSN 1355-8382
    DOI 10.1261/rna.7135305
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.

    Sentis, Stephanie / Le Romancer, Murielle / Bianchin, Claire / Rostan, Marie-Claude / Corbo, Laura

    Molecular endocrinology (Baltimore, Md.)

    2005  Volume 19, Issue 11, Page(s) 2671–2684

    Abstract: The steroid hormone 17beta-estradiol (estrogen) plays a significant role in the normal physiology of the mammary gland and breast cancer development primarily through binding to its receptor, the estrogen receptor alpha (ERalpha). ERalpha is a nuclear ... ...

    Abstract The steroid hormone 17beta-estradiol (estrogen) plays a significant role in the normal physiology of the mammary gland and breast cancer development primarily through binding to its receptor, the estrogen receptor alpha (ERalpha). ERalpha is a nuclear transcription factor undergoing different types of posttranslational modifications, i.e. phosphorylation, acetylation, and ubiquitination, which regulate its transcriptional activation and/or stability. Here we identify ERalpha as a new target for small ubiquitin-like modifier (SUMO)-1 modification in intact cells and in vitro. Moreover, ERalpha sumoylation occurs strictly in the presence of hormone. SUMO-1 appears to regulate ERalpha-dependent transcription. Using a series of mutants, we demonstrated that ERalpha is sumoylated at conserved lysine residues within the hinge region. Mutations that prevented SUMO modification impaired ERalpha-induced transcription without influencing ERalpha cellular localization. In addition to identifying protein inhibitor of activated signal transducer and activator of transcription (PIAS)1 and PIAS3 as E3 ligases for ERalpha, we also found that PIAS1 and PIAS3, as well as Ubc9, modulated ERalpha-dependent transcription independently from their SUMO-1 conjugation activity. These findings identify sumoylation as a new mechanism modulating ERalpha-dependent cellular response and provide a link between the SUMO and estrogen pathways.
    MeSH term(s) Animals ; COS Cells ; Cell Line, Tumor ; Cercopithecus aethiops ; Estradiol/metabolism ; Estrogen Receptor alpha/chemistry ; Estrogen Receptor alpha/genetics ; Estrogen Receptor alpha/metabolism ; Gene Expression Regulation ; Humans ; Molecular Chaperones/genetics ; Molecular Chaperones/metabolism ; Mutation ; Protein Inhibitors of Activated STAT/genetics ; Protein Inhibitors of Activated STAT/metabolism ; SUMO-1 Protein/metabolism ; Sequence Deletion ; Small Ubiquitin-Related Modifier Proteins/genetics ; Small Ubiquitin-Related Modifier Proteins/metabolism ; Transcription, Genetic ; Transcriptional Activation ; Ubiquitin-Conjugating Enzymes/metabolism
    Chemical Substances Estrogen Receptor alpha ; Molecular Chaperones ; PIAS1 protein, human ; PIAS3 protein, human ; Protein Inhibitors of Activated STAT ; SUMO-1 Protein ; Small Ubiquitin-Related Modifier Proteins ; Estradiol (4TI98Z838E) ; Ubiquitin-Conjugating Enzymes (EC 2.3.2.23) ; ubiquitin-conjugating enzyme UBC9 (EC 6.3.2.-)
    Language English
    Publishing date 2005-11
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 639167-9
    ISSN 1944-9917 ; 0888-8809
    ISSN (online) 1944-9917
    ISSN 0888-8809
    DOI 10.1210/me.2005-0042
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Arachidonic acid increases intracellular calcium in erythrocytes.

    Soldati, Laura / Lombardi, Cinzia / Adamo, Donatella / Terranegra, Annalisa / Bianchin, Cristiana / Bianchi, Giuseppe / Vezzoli, Giuseppe

    Biochemical and biophysical research communications

    2002  Volume 293, Issue 3, Page(s) 974–978

    Abstract: Recently, we have measured in erythrocytes a voltage-modulated and dihydropyridine-inhibited calcium influx. Since arachidonic acid and other polyunsaturated fatty acids influence the activities of most ion channels, we studied their effects on the ... ...

    Abstract Recently, we have measured in erythrocytes a voltage-modulated and dihydropyridine-inhibited calcium influx. Since arachidonic acid and other polyunsaturated fatty acids influence the activities of most ion channels, we studied their effects on the erythrocyte Ca(2+) influx. It was measured on fresh erythrocytes, isolated from healthy donors, using the fluorescent dye Fura 2 as indicator of [Ca(2+)](i). AA (5-50 microM) and EPA (20-30 microM) stimulated a concentration-dependent increase in [Ca(2+)](i), deriving from extracellular calcium (1 mM), without affecting the intra- and extracellular pH and membrane voltage. The Ca(2+) influx rate varied from 0.5 to 3 nM Ca(2+)/s in the presence of AA and from 0.9 to 1.7 nM Ca(2+)/s with EPA. The Ca(2+) influx elicited by AA and EPA was not inhibited by dihydropyridines, while cyclooxygenase inhibitors were effective and PGE1 or PGE2 did not produce any effect. We conclude that AA could activate an erythrocyte voltage-independent Ca(2+) transport via an intermediate product of cyclooxygenase pathway; however, a direct interaction with the membrane lipid-protein cannot be excluded.
    MeSH term(s) 5,8,11,14-Eicosatetraynoic Acid/pharmacology ; Arachidonic Acid/pharmacology ; Calcium/metabolism ; Calcium Channel Blockers/pharmacology ; Cyclooxygenase Inhibitors/pharmacology ; Cytoplasm/metabolism ; Eicosapentaenoic Acid/pharmacology ; Erythrocytes/drug effects ; Erythrocytes/metabolism ; Humans ; Kinetics ; Nifedipine/pharmacology ; Oleic Acid/pharmacology ; Prostaglandins/pharmacology
    Chemical Substances Calcium Channel Blockers ; Cyclooxygenase Inhibitors ; Prostaglandins ; 5,8,11,14-Eicosatetraynoic Acid (1191-85-1) ; Arachidonic Acid (27YG812J1I) ; Oleic Acid (2UMI9U37CP) ; Eicosapentaenoic Acid (AAN7QOV9EA) ; Nifedipine (I9ZF7L6G2L) ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2002-05-10
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 205723-2
    ISSN 0006-291X ; 0006-291X
    ISSN (online) 0006-291X
    ISSN 0006-291X
    DOI 10.1016/S0006-291X(02)00327-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Vitamin D receptor mRNA measured in leukocytes with the TaqMan fluorogenic detection system: effect of calcitriol administration.

    Soldati, Laura / Adamo, Donatella / Bianchin, Cristiana / Arcidiacono, Teresa / Terranegra, Annalisa / Bianchi, Maria Luisa / Mora, Stefano / Cusi, Daniele / Vezzoli, Giuseppe

    Clinical chemistry

    2004  Volume 50, Issue 8, Page(s) 1315–1321

    Abstract: Background: The aim of the present study was to investigate the interactions between the circulating concentrations of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] and the mRNA concentration of its specific nuclear receptor in human leukocytes.: Methods: ... ...

    Abstract Background: The aim of the present study was to investigate the interactions between the circulating concentrations of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] and the mRNA concentration of its specific nuclear receptor in human leukocytes.
    Methods: We measured vitamin D receptor (VDR) mRNA extracted from leukocytes by use of TaqMan fluorescence analysis applied to the reverse transcription-PCR (RT-PCR) technique in 16 volunteers before and after calcitriol administration. VDR mRNA was also measured in leukocytes from calcium-stone-formers (37 hypercalciuric and 34 normocalciuric patients). The relationship between VDR mRNA concentrations and genetic VDR polymorphisms was analyzed in these patients.
    Results: Imprecision (CV) of RT-PCR was 1.3% within assay (n = 10) and 1.7% between assays (n = 4). Oral 1,25(OH)2D3 increased mean (SE) serum 1,25(OH)2D3 1.6 (0.3)-fold and VDR mRNA 1.6 (0.1)-fold 8 h after administration. The maximum VDR mRNA was reached 3.6 (1.3) h after 1,25(OH)2D3 ingestion. No differences in leukocyte VDR mRNA concentrations were found between normocalciuric and hypercalciuric stone-formers in the absence of stimulation. Finally, no association was found between VDR mRNA concentrations and genetic VDR polymorphisms in stone-formers.
    Conclusions: The TaqMan RT-PCR assay is a rapid and accurate method to measure VDR mRNA, and leukocytes are a useful model to study VDR and 1,25(OH)2D3 interactions. In humans, VDR mRNA is increased by agonist 1,25(OH)2D3, a finding resembling previously reported results obtained in cellular and animal models.
    MeSH term(s) Adult ; Calcitriol/blood ; Calcitriol/pharmacology ; Calcium/urine ; Female ; Genotype ; Humans ; Kidney Calculi/urine ; Leukocytes/metabolism ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; RNA, Messenger/biosynthesis ; RNA, Messenger/blood ; Receptors, Calcitriol/biosynthesis ; Receptors, Calcitriol/blood ; Receptors, Calcitriol/genetics ; Reverse Transcriptase Polymerase Chain Reaction/methods ; Taq Polymerase
    Chemical Substances RNA, Messenger ; Receptors, Calcitriol ; Taq Polymerase (EC 2.7.7.-) ; Calcitriol (FXC9231JVH) ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2004-05-20
    Publishing country England
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80102-1
    ISSN 1530-8561 ; 0009-9147
    ISSN (online) 1530-8561
    ISSN 0009-9147
    DOI 10.1373/clinchem.2004.033126
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Intestinal calcium absorption is associated with bone mass in stone-forming women with idiopathic hypercalciuria.

    Vezzoli, Giuseppe / Rubinacci, Alessandro / Bianchin, Cristiana / Arcidiacono, Teresa / Giambona, Salvatore / Mignogna, Giovanna / Fochesato, Elena / Terranegra, Annalisa / Cusi, Daniele / Soldati, Laura

    American journal of kidney diseases : the official journal of the National Kidney Foundation

    2003  Volume 42, Issue 6, Page(s) 1177–1183

    Abstract: Background: Patients with idiopathic hypercalciuria are predisposed to osteoporosis despite their high enteral calcium absorption. Conversely, low calcium absorption has been reported in patients with osteoporosis. Because bone loss occurs earlier in ... ...

    Abstract Background: Patients with idiopathic hypercalciuria are predisposed to osteoporosis despite their high enteral calcium absorption. Conversely, low calcium absorption has been reported in patients with osteoporosis. Because bone loss occurs earlier in women, this work explores the relationship between bone mineral density (BMD) and calcium absorption in premenopausal and postmenopausal hypercalciuric stone-forming women.
    Methods: BMD and intestinal calcium absorption were compared in 64 hypercalciuric and 42 normocalciuric calcium stone-forming women. Calcium absorption was assessed by using strontium as a surrogate marker for calcium. Strontium was administered to patients as an oral load, then measured in blood to calculate absorption after 60 minutes. Femoral and lumbar-spine BMD were measured by dual-energy x-ray absorptiometry.
    Results: Strontium absorption was significantly increased in hypercalciuric stone formers, whereas BMD z score was decreased in hypercalciuric patients at the lumbar spine, but not the femur. The increase in strontium absorption was detected in both postmenopausal (n = 29) and premenopausal (n = 35) hypercalciuric patients. The decrease in lumbar-spine BMD was confirmed in postmenopausal, but not premenopausal, hypercalciuric patients. Strontium absorption was greater in hypercalciuric patients with a lumbar-spine BMD z score of -2 or less (n = 10) than in those with a score greater than -2 (n = 54). Multiple stepwise regression showed that lumbar-spine BMD was related negatively to intestinal strontium absorption and age in hypercalciuric patients.
    Conclusion: Results of the strontium absorption test suggest that the increase in calcium absorption is associated with a decrease in lumbar-spine BMD in hypercalciuric stone-forming women. Hypercalciuric stone-forming women with high calcium intestinal absorption denote a group of patients predisposed to loss of bone mass.
    MeSH term(s) Absorptiometry, Photon ; Adult ; Aged ; Amino Acids/urine ; Bone Density ; Calcium/blood ; Calcium/pharmacokinetics ; Calcium/urine ; Creatinine/blood ; Female ; Femur/chemistry ; Humans ; Intestinal Absorption ; Lumbar Vertebrae/chemistry ; Middle Aged ; Natriuresis ; Osteoporosis, Postmenopausal/etiology ; Osteoporosis, Postmenopausal/metabolism ; Parathyroid Hormone/blood ; Postmenopause ; Premenopause ; Strontium/pharmacokinetics ; Urinary Calculi/etiology ; Urinary Calculi/metabolism
    Chemical Substances Amino Acids ; Parathyroid Hormone ; deoxypyridinoline (90032-33-0) ; Creatinine (AYI8EX34EU) ; Calcium (SY7Q814VUP) ; Strontium (YZS2RPE8LE)
    Language English
    Publishing date 2003-12
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 604539-x
    ISSN 1523-6838 ; 0272-6386
    ISSN (online) 1523-6838
    ISSN 0272-6386
    DOI 10.1053/j.ajkd.2003.08.018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: BTG2 antiproliferative protein interacts with the human CCR4 complex existing in vivo in three cell-cycle-regulated forms.

    Morel, Anne-Pierre / Sentis, Stéphanie / Bianchin, Claire / Le Romancer, Muriel / Jonard, Laurence / Rostan, Marie-Claude / Rimokh, Ruth / Corbo, Laura

    Journal of cell science

    2003  Volume 116, Issue Pt 14, Page(s) 2929–2936

    Abstract: The yeast CCR4-NOT complex exists in two forms (1.0 and 1.9 MDa) that share several common subunits, including yCCR4, yCAF1 and five NOT proteins (NOT1-5). Here, we report that different complexes containing mammalian homologs of CCR4-NOT subunits exist ... ...

    Abstract The yeast CCR4-NOT complex exists in two forms (1.0 and 1.9 MDa) that share several common subunits, including yCCR4, yCAF1 and five NOT proteins (NOT1-5). Here, we report that different complexes containing mammalian homologs of CCR4-NOT subunits exist in mammalian cells, with estimated sizes of approximately 1.9 MDa, approximately 1 MDa and approximately 650 kDa, and that BTG2, a member of a protein family with antiproliferative functions, can associate with these complexes. Immunoprecipitation and gel filtration experiments established that BTG2 interacts in vivo with hCCR4 protein via hCAF1 and hPOP2. Moreover, we show that hCCR4, as well as hCAF1 and BTG2, modulate the transcription regulation mediated by ERalpha. Finally, we demonstrate that the cellular localization of hCAF1 and the cell content in hCAF1-containing complexes change as cells progress from quiescence to S phase. These findings suggest that the different regulatory pathways in which hCAF1 is involved, notably transcription regulation and mRNA turnover, may occur through distinct CCR4 complexes in the course of cell-cycle progression.
    MeSH term(s) Cell Cycle ; Cell Separation ; Chromatography, Gel ; Cytoplasm/metabolism ; Estrogen Receptor alpha ; Flow Cytometry ; Genes, Reporter ; Genes, Tumor Suppressor/physiology ; Genetic Vectors ; Glutathione Transferase/metabolism ; HeLa Cells ; Humans ; Immediate-Early Proteins/metabolism ; Immediate-Early Proteins/physiology ; Immunoblotting ; Microscopy, Fluorescence ; Precipitin Tests ; Protein Binding ; Proteins ; RNA, Messenger/metabolism ; Receptors, Estrogen/metabolism ; Recombinant Proteins/metabolism ; S Phase ; Transcription Factors/metabolism ; Transcription, Genetic ; Transfection ; Tumor Suppressor Proteins ; Two-Hybrid System Techniques
    Chemical Substances CNOT8 protein, human ; Estrogen Receptor alpha ; Immediate-Early Proteins ; Proteins ; RNA, Messenger ; Receptors, Estrogen ; Recombinant Proteins ; Transcription Factors ; Tumor Suppressor Proteins ; BTG2 protein, human (141490-22-4) ; Glutathione Transferase (EC 2.5.1.18)
    Language English
    Publishing date 2003-07-15
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2993-2
    ISSN 1477-9137 ; 0021-9533
    ISSN (online) 1477-9137
    ISSN 0021-9533
    DOI 10.1242/jcs.00480
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: [Basal values and circadian variations of testosterone, 17beta-oestradiol, FSH and LH in the plasma of normal adult males].

    De Aloysio, D / Fronticelli, A / Bolelli, G F / Vecchi, F / Bianchin, C

    Acta Europaea fertilitatis

    1975  Volume 6, Issue 1, Page(s) 73–88

    Abstract: The Authors have determined the concentrations of Testosterone, 17beta-oestradiol, FSH and LH by of radioimmunologic assay in blood of seventy normal adult men blood drawn between eight and eleven a.m.) and in blood of thirteen normal adult men blood ... ...

    Abstract The Authors have determined the concentrations of Testosterone, 17beta-oestradiol, FSH and LH by of radioimmunologic assay in blood of seventy normal adult men blood drawn between eight and eleven a.m.) and in blood of thirteen normal adult men blood drawn at eight and twelve a.m., four and eight p.m.). Average values under basal conditions, and circadian variations have been discussed and confronted with those obtained by other authors.
    MeSH term(s) Adult ; Circadian Rhythm ; Estradiol/blood ; Follicle Stimulating Hormone/blood ; Humans ; Luteinizing Hormone/blood ; Male ; Testosterone/blood
    Chemical Substances Testosterone (3XMK78S47O) ; Estradiol (4TI98Z838E) ; Luteinizing Hormone (9002-67-9) ; Follicle Stimulating Hormone (9002-68-0)
    Language Italian
    Publishing date 1975-03
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 420121-8
    ISSN 0587-2421
    ISSN 0587-2421
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients.

    Vezzoli, Giuseppe / Tanini, Annalisa / Ferrucci, Luigi / Soldati, Laura / Bianchin, Cristiana / Franceschelli, Francesco / Malentacchi, Cecilia / Porfirio, Berardino / Adamo, Donatella / Terranegra, Annalisa / Falchetti, Alberto / Cusi, Daniele / Bianchi, Giuseppe / Brandi, Maria Luisa

    Journal of the American Society of Nephrology : JASN

    2002  Volume 13, Issue 10, Page(s) 2517–2523

    Abstract: Calcium-sensing receptor (CaSR) is a plasma membrane protein that regulates tubular reabsorption of Ca. To establish its role in idiopathic hypercalciuria, the association of urinary Ca excretion with the polymorphisms of CASR gene has been studied in ... ...

    Abstract Calcium-sensing receptor (CaSR) is a plasma membrane protein that regulates tubular reabsorption of Ca. To establish its role in idiopathic hypercalciuria, the association of urinary Ca excretion with the polymorphisms of CASR gene has been studied in healthy subjects and in hypercalciuric and normocalciuric Ca stone formers. CASR exon 7 single nucleotide polymorphisms (SNP), G/T at codon 986, G/A at codon 990, and C/G at codon 1011, were evaluated by PCR amplification and direct sequencing in 97 normocalciuric stone formers, 134 hypercalciuric stone formers, and 101 normocalciuric healthy controls. Four haplotypes were defined on the basis of CASR gene SNP: haplotype 1 was characterized by the most frequent sequence; haplotypes 2, 3, or 4 by the presence of a single polymorphic variant at codon 986, 990, or 1011, respectively. The relative risk of hypercalciuria was calculated with multinomial logistic regression and was significantly increased only in individuals carrying haplotype 3 (Odds ratio, 13.0 [95% confidence interval, 1.7 to 99.4]). Accordingly, Ca excretion was higher in subjects bearing haplotype 3, whereas those bearing haplotype 2 showed a slight increase of plasma Ca concentration. Multiple regression analysis showed that haplotype 3 explained 4.1% of the total variance of Ca excretion and 12.6% of the variance explained by the variables considered in the study. In conclusion, CASR gene could be a component of the complex genetic background regulating Ca excretion. Arg990Gly polymorphism could facilitate activation of CaSR and increase Ca excretion and susceptibility to idiopathic hypercalciuria.
    MeSH term(s) Calcium/urine ; Female ; Gene Frequency ; Haplotypes ; Humans ; Kidney Calculi/genetics ; Kidney Calculi/urine ; Male ; Middle Aged ; Phenotype ; Polymorphism, Genetic ; Receptors, Calcium-Sensing ; Receptors, Cell Surface/genetics ; Reference Values
    Chemical Substances Receptors, Calcium-Sensing ; Receptors, Cell Surface ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2002-08-28
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1085942-1
    ISSN 1533-3450 ; 1046-6673
    ISSN (online) 1533-3450
    ISSN 1046-6673
    DOI 10.1097/01.asn.0000030077.72157.d2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: D-Meson Azimuthal Anisotropy in Midcentral Pb-Pb Collisions at sqrt[s]_{NN}=5.02  TeV.

    Acharya, S / Adamová, D / Adolfsson, J / Aggarwal, M M / Aglieri Rinella, G / Agnello, M / Agrawal, N / Ahammed, Z / Ahmad, N / Ahn, S U / Aiola, S / Akindinov, A / Alam, S N / Alba, J L B / Albuquerque, D S D / Aleksandrov, D / Alessandro, B / Alfaro Molina, R / Alici, A /
    Alkin, A / Alme, J / Alt, T / Altenkamper, L / Altsybeev, I / Alves Garcia Prado, C / Andrei, C / Andreou, D / Andrews, H A / Andronic, A / Anguelov, V / Anson, C / Antičić, T / Antinori, F / Antonioli, P / Anwar, R / Aphecetche, L / Appelshäuser, H / Arcelli, S / Arnaldi, R / Arnold, O W / Arsene, I C / Arslandok, M / Audurier, B / Augustinus, A / Averbeck, R / Azmi, M D / Badalà, A / Baek, Y W / Bagnasco, S / Bailhache, R / Bala, R / Baldisseri, A / Ball, M / Baral, R C / Barbano, A M / Barbera, R / Barile, F / Barioglio, L / Barnaföldi, G G / Barnby, L S / Barret, V / Bartalini, P / Barth, K / Bartsch, E / Basile, M / Bastid, N / Basu, S / Batigne, G / Batyunya, B / Batzing, P C / Bearden, I G / Beck, H / Bedda, C / Behera, N K / Belikov, I / Bellini, F / Bello Martinez, H / Bellwied, R / Beltran, L G E / Belyaev, V / Bencedi, G / Beole, S / Bercuci, A / Berdnikov, Y / Berenyi, D / Bertens, R A / Berzano, D / Betev, L / Bhasin, A / Bhat, I R / Bhati, A K / Bhattacharjee, B / Bhom, J / Bianchi, L / Bianchi, N / Bianchin, C / Bielčík, J / Bielčíková, J / Bilandzic, A / Biro, G / Biswas, R / Biswas, S / Blair, J T / Blau, D / Blume, C / Boca, G / Bock, F / Bogdanov, A / Boldizsár, L / Bombara, M / Bonomi, G / Bonora, M / Book, J / Borel, H / Borissov, A / Borri, M / Botta, E / Bourjau, C / Bratrud, L / Braun-Munzinger, P / Bregant, M / Broker, T A / Broz, M / Brucken, E J / Bruna, E / Bruno, G E / Budnikov, D / Buesching, H / Bufalino, S / Buhler, P / Buncic, P / Busch, O / Buthelezi, Z / Butt, J B / Buxton, J T / Cabala, J / Caffarri, D / Caines, H / Caliva, A / Calvo Villar, E / Camerini, P / Capon, A A / Carena, F / Carena, W / Carnesecchi, F / Castillo Castellanos, J / Castro, A J / Casula, E A R / Ceballos Sanchez, C / Cerello, P / Chandra, S / Chang, B / Chapeland, S / Chartier, M / Charvet, J L / Chattopadhyay, S / Chauvin, A / Cherney, M / Cheshkov, C / Cheynis, B / Chibante Barroso, V / Chinellato, D D / Cho, S / Chochula, P / Choi, K / Chojnacki, M / Choudhury, S / Chowdhury, T / Christakoglou, P / Christensen, C H / Christiansen, P / Chujo, T / Chung, S U / Cicalo, C / Cifarelli, L / Cindolo, F / Cleymans, J / Colamaria, F / Colella, D / Collu, A / Colocci, M / Concas, M / Conesa Balbastre, G / Conesa Del Valle, Z / Connors, M E / Contreras, J G / Cormier, T M / Corrales Morales, Y / Cortés Maldonado, I / Cortese, P / Cosentino, M R / Costa, F / Costanza, S / Crkovská, J / Crochet, P / Cuautle, E / Cunqueiro, L / Dahms, T / Dainese, A / Danisch, M C / Danu, A / Das, D / Das, I / Das, S / Dash, A / Dash, S / De, S / De Caro, A / de Cataldo, G / de Conti, C / de Cuveland, J / De Falco, A / De Gruttola, D / De Marco, N / De Pasquale, S / De Souza, R D / Degenhardt, H F / Deisting, A / Deloff, A / Deplano, C / Dhankher, P / Di Bari, D / Di Mauro, A / Di Nezza, P / Di Ruzza, B / Diaz Corchero, M A / Dietel, T / Dillenseger, P / Divià, R / Djuvsland, Ø / Dobrin, A / Domenicis Gimenez, D / Dönigus, B / Dordic, O / Doremalen, L V V / Dubey, A K / Dubla, A / Ducroux, L / Duggal, A K / Dupieux, P / Ehlers, R J / Elia, D / Endress, E / Engel, H / Epple, E / Erazmus, B / Erhardt, F / Espagnon, B / Esumi, S / Eulisse, G / Eum, J / Evans, D / Evdokimov, S / Fabbietti, L / Faivre, J / Fantoni, A / Fasel, M / Feldkamp, L / Feliciello, A / Feofilov, G / Ferencei, J / Fernández Téllez, A / Ferreiro, E G / Ferretti, A / Festanti, A / Feuillard, V J G / Figiel, J / Figueredo, M A S / Filchagin, S / Finogeev, D / Fionda, F M / Fiore, E M / Floris, M / Foertsch, S / Foka, P / Fokin, S / Fragiacomo, E / Francescon, A / Francisco, A / Frankenfeld, U / Fronze, G G / Fuchs, U / Furget, C / Furs, A / Fusco Girard, M / Gaardhøje, J J / Gagliardi, M / Gago, A M / Gajdosova, K / Gallio, M / Galvan, C D / Ganoti, P / Gao, C / Garabatos, C / Garcia-Solis, E / Garg, K / Gargiulo, C / Gasik, P / Gauger, E F / Gay Ducati, M B / Germain, M / Ghosh, J / Ghosh, P / Ghosh, S K / Gianotti, P / Giubellino, P / Giubilato, P / Gladysz-Dziadus, E / Glässel, P / Goméz Coral, D M / Gomez Ramirez, A / Gonzalez, A S / Gonzalez, V / González-Zamora, P / Gorbunov, S / Görlich, L / Gotovac, S / Grabski, V / Graczykowski, L K / Graham, K L / Greiner, L / Grelli, A / Grigoras, C / Grigoriev, V / Grigoryan, A / Grigoryan, S / Grion, N / Gronefeld, J M / Grosa, F / Grosse-Oetringhaus, J F / Grosso, R / Gruber, L / Guber, F / Guernane, R / Guerzoni, B / Gulbrandsen, K / Gunji, T / Gupta, A / Gupta, R / Guzman, I B / Haake, R / Hadjidakis, C / Hamagaki, H / Hamar, G / Hamon, J C / Haque, M R / Harris, J W / Harton, A / Hassan, H / Hatzifotiadou, D / Hayashi, S / Heckel, S T / Hellbär, E / Helstrup, H / Herghelegiu, A / Herrera Corral, G / Herrmann, F / Hess, B A / Hetland, K F / Hillemanns, H / Hills, C / Hippolyte, B / Hladky, J / Hohlweger, B / Horak, D / Hornung, S / Hosokawa, R / Hristov, P / Hughes, C / Humanic, T J / Hussain, N / Hussain, T / Hutter, D / Hwang, D S / Iga Buitron, S A / Ilkaev, R / Inaba, M / Ippolitov, M / Irfan, M / Isakov, V / Ivanov, M / Ivanov, V / Izucheev, V / Jacak, B / Jacazio, N / Jacobs, P M / Jadhav, M B / Jadlovsky, J / Jaelani, S / Jahnke, C / Jakubowska, M J / Janik, M A / Jayarathna, P H S Y / Jena, C / Jena, S / Jercic, M / Jimenez Bustamante, R T / Jones, P G / Jusko, A / Kalinak, P / Kalweit, A / Kang, J H / Kaplin, V / Kar, S / Karasu Uysal, A / Karavichev, O / Karavicheva, T / Karayan, L / Karczmarczyk, P / Karpechev, E / Kebschull, U / Keidel, R / Keijdener, D L D / Keil, M / Ketzer, B / Khabanova, Z / Khan, P / Khan, S A / Khanzadeev, A / Kharlov, Y / Khatun, A / Khuntia, A / Kielbowicz, M M / Kileng, B / Kim, B / Kim, D / Kim, D J / Kim, H / Kim, J S / Kim, J / Kim, M / Kim, S / Kim, T / Kirsch, S / Kisel, I / Kiselev, S / Kisiel, A / Kiss, G / Klay, J L / Klein, C / Klein, J / Klein-Bösing, C / Klewin, S / Kluge, A / Knichel, M L / Knospe, A G / Kobdaj, C / Kofarago, M / Kollegger, T / Kolojvari, A / Kondratiev, V / Kondratyeva, N / Kondratyuk, E / Konevskikh, A / Konyushikhin, M / Kopcik, M / Kour, M / Kouzinopoulos, C / Kovalenko, O / Kovalenko, V / Kowalski, M / Koyithatta Meethaleveedu, G / Králik, I / Kravčáková, A / Krivda, M / Krizek, F / Kryshen, E / Krzewicki, M / Kubera, A M / Kučera, V / Kuhn, C / Kuijer, P G / Kumar, A / Kumar, J / Kumar, L / Kumar, S / Kundu, S / Kurashvili, P / Kurepin, A / Kurepin, A B / Kuryakin, A / Kushpil, S / Kweon, M J / Kwon, Y / La Pointe, S L / La Rocca, P / Lagana Fernandes, C / Lai, Y S / Lakomov, I / Langoy, R / Lapidus, K / Lara, C / Lardeux, A / Lattuca, A / Laudi, E / Lavicka, R / Lazaridis, L / Lea, R / Leardini, L / Lee, S / Lehas, F / Lehner, S / Lehrbach, J / Lemmon, R C / Lenti, V / Leogrande, E / León Monzón, I / Lévai, P / Li, S / Li, X / Lien, J / Lietava, R / Lim, B / Lindal, S / Lindenstruth, V / Lindsay, S W / Lippmann, C / Lisa, M A / Litichevskyi, V / Ljunggren, H M / Llope, W J / Lodato, D F / Loenne, P I / Loginov, V / Loizides, C / Loncar, P / Lopez, X / López Torres, E / Lowe, A / Luettig, P / Luhder, J R / Lunardon, M / Luparello, G / Lupi, M / Lutz, T H / Maevskaya, A / Mager, M / Mahajan, S / Mahmood, S M / Maire, A / Majka, R D / Malaev, M / Malinina, L / Mal'Kevich, D / Malzacher, P / Mamonov, A / Manko, V / Manso, F / Manzari, V / Mao, Y / Marchisone, M / Mareš, J / Margagliotti, G V / Margotti, A / Margutti, J / Marín, A / Markert, C / Marquard, M / Martin, N A / Martinengo, P / Martinez, J A L / Martínez, M I / Martínez García, G / Martinez Pedreira, M / Mas, A / Masciocchi, S / Masera, M / Masoni, A / Masson, E / Mastroserio, A / Mathis, A M / Matyja, A / Mayer, C / Mazer, J / Mazzilli, M / Mazzoni, M A / Meddi, F / Melikyan, Y / Menchaca-Rocha, A / Meninno, E / Mercado Pérez, J / Meres, M / Mhlanga, S / Miake, Y / Mieskolainen, M M / Mihaylov, D / Mihaylov, D L / Mikhaylov, K / Milano, L / Milosevic, J / Mischke, A / Mishra, A N / Miśkowiec, D / Mitra, J / Mitu, C M / Mohammadi, N / Mohanty, B / Mohisin Khan, M / Montes, E / Moreira De Godoy, D A / Moreno, L A P / Moretto, S / Morreale, A / Morsch, A / Muccifora, V / Mudnic, E / Mühlheim, D / Muhuri, S / Mukherjee, M / Mulligan, J D / Munhoz, M G / Münning, K / Munzer, R H / Murakami, H / Murray, S / Musa, L / Musinsky, J / Myers, C J / Myrcha, J W / Naik, B / Nair, R / Nandi, B K / Nania, R / Nappi, E / Narayan, A / Naru, M U / Natal da Luz, H / Nattrass, C / Navarro, S R / Nayak, K / Nayak, R / Nayak, T K / Nazarenko, S / Nedosekin, A / Negrao De Oliveira, R A / Nellen, L / Nesbo, S V / Ng, F / Nicassio, M / Niculescu, M / Niedziela, J / Nielsen, B S / Nikolaev, S / Nikulin, S / Nikulin, V / Nobuhiro, A / Noferini, F / Nomokonov, P / Nooren, G / Noris, J C C / Norman, J / Nyanin, A / Nystrand, J / Oeschler, H / Oh, S / Ohlson, A / Okubo, T / Olah, L / Oleniacz, J / Oliveira Da Silva, A C / Oliver, M H / Onderwaater, J / Oppedisano, C / Orava, R / Oravec, M / Ortiz Velasquez, A / Oskarsson, A / Otwinowski, J / Oyama, K / Pachmayer, Y / Pacik, V / Pagano, D / Pagano, P / Paić, G / Palni, P / Pan, J / Pandey, A K / Panebianco, S / Papikyan, V / Pappalardo, G S / Pareek, P / Park, J / Parmar, S / Passfeld, A / Pathak, S P / Paticchio, V / Patra, R N / Paul, B / Pei, H / Peitzmann, T / Peng, X / Pereira, L G / Pereira Da Costa, H / Peresunko, D / Perez Lezama, E / Peskov, V / Pestov, Y / Petráček, V / Petrov, V / Petrovici, M / Petta, C / Pezzi, R P / Piano, S / Pikna, M / Pillot, P / Pimentel, L O D L / Pinazza, O / Pinsky, L / Piyarathna, D B / Płoskoń, M / Planinic, M / Pliquett, F / Pluta, J / Pochybova, S / Podesta-Lerma, P L M / Poghosyan, M G / Polichtchouk, B / Poljak, N / Poonsawat, W / Pop, A / Poppenborg, H / Porteboeuf-Houssais, S / Porter, J / Pozdniakov, V / Prasad, S K / Preghenella, R / Prino, F / Pruneau, C A / Pshenichnov, I / Puccio, M / Puddu, G / Pujahari, P / Punin, V / Putschke, J / Rachevski, A / Raha, S / Rajput, S / Rak, J / Rakotozafindrabe, A / Ramello, L / Rami, F / Rana, D B / Raniwala, R / Raniwala, S / Räsänen, S S / Rascanu, B T / Rathee, D / Ratza, V / Ravasenga, I / Read, K F / Redlich, K / Rehman, A / Reichelt, P / Reidt, F / Ren, X / Renfordt, R / Reolon, A R / Reshetin, A / Reygers, K / Riabov, V / Ricci, R A / Richert, T / Richter, M / Riedler, P / Riegler, W / Riggi, F / Ristea, C / Rodríguez Cahuantzi, M / Røed, K / Rogochaya, E / Rohr, D / Röhrich, D / Rokita, P S / Ronchetti, F / Rosas, E D / Rosnet, P / Rossi, A / Rotondi, A / Roukoutakis, F / Roy, A / Roy, C / Roy, P / Rubio Montero, A J / Rueda, O V / Rui, R / Rumyantsev, B / Rustamov, A / Ryabinkin, E / Ryabov, Y / Rybicki, A / Saarinen, S / Sadhu, S / Sadovsky, S / Šafařík, K / Saha, S K / Sahlmuller, B / Sahoo, B / Sahoo, P / Sahoo, R / Sahoo, S / Sahu, P K / Saini, J / Sakai, S / Saleh, M A / Salzwedel, J / Sambyal, S / Samsonov, V / Sandoval, A / Sarkar, D / Sarkar, N / Sarma, P / Sas, M H P / Scapparone, E / Scarlassara, F / Scharenberg, R P / Scheid, H S / Schiaua, C / Schicker, R / Schmidt, C / Schmidt, H R / Schmidt, M O / Schmidt, M / Schmidt, N V / Schuchmann, S / Schukraft, J / Schutz, Y / Schwarz, K / Schweda, K / Scioli, G / Scomparin, E / Scott, R / Šefčík, M / Seger, J E / Sekiguchi, Y / Sekihata, D / Selyuzhenkov, I / Senosi, K / Senyukov, S / Serradilla, E / Sett, P / Sevcenco, A / Shabanov, A / Shabetai, A / Shahoyan, R / Shaikh, W / Shangaraev, A / Sharma, A / Sharma, M / Sharma, N / Sheikh, A I / Shigaki, K / Shou, Q / Shtejer, K / Sibiriak, Y / Siddhanta, S / Sielewicz, K M / Siemiarczuk, T / Silvermyr, D / Silvestre, C / Simatovic, G / Simonetti, G / Singaraju, R / Singh, R / Singhal, V / Sinha, T / Sitar, B / Sitta, M / Skaali, T B / Slupecki, M / Smirnov, N / Snellings, R J M / Snellman, T W / Song, J / Song, M / Soramel, F / Sorensen, S / Sozzi, F / Spiriti, E / Sputowska, I / Srivastava, B K / Stachel, J / Stan, I / Stankus, P / Stenlund, E / Stocco, D / Storetvedt, M M / Strmen, P / Suaide, A A P / Sugitate, T / Suire, C / Suleymanov, M / Suljic, M / Sultanov, R / Šumbera, M / Sumowidagdo, S / Suzuki, K / Swain, S / Szabo, A / Szarka, I / Tabassam, U / Takahashi, J / Tambave, G J / Tanaka, N / Tarhini, M / Tariq, M / Tarzila, M G / Tauro, A / Tejeda Muñoz, G / Telesca, A / Terasaki, K / Terrevoli, C / Teyssier, B / Thakur, D / Thakur, S / Thomas, D / Thoresen, F / Tieulent, R / Tikhonov, A / Timmins, A R / Toia, A / Tripathy, S / Trogolo, S / Trombetta, G / Tropp, L / Trubnikov, V / Trzaska, W H / Trzeciak, B A / Tsuji, T / Tumkin, A / Turrisi, R / Tveter, T S / Ullaland, K / Umaka, E N / Uras, A / Usai, G L / Utrobicic, A / Vala, M / Van Der Maarel, J / Van Hoorne, J W / van Leeuwen, M / Vanat, T / Vande Vyvre, P / Varga, D / Vargas, A / Vargyas, M / Varma, R / Vasileiou, M / Vasiliev, A / Vauthier, A / Vázquez Doce, O / Vechernin, V / Veen, A M / Velure, A / Vercellin, E / Vergara Limón, S / Vernet, R / Vértesi, R / Vickovic, L / Vigolo, S / Viinikainen, J / Vilakazi, Z / Villalobos Baillie, O / Villatoro Tello, A / Vinogradov, A / Vinogradov, L / Virgili, T / Vislavicius, V / Vodopyanov, A / Völkl, M A / Voloshin, K / Voloshin, S A / Volpe, G / von Haller, B / Vorobyev, I / Voscek, D / Vranic, D / Vrláková, J / Wagner, B / Wang, H / Wang, M / Watanabe, D / Watanabe, Y / Weber, M / Weber, S G / Weiser, D F / Wenzel, S C / Wessels, J P / Westerhoff, U / Whitehead, A M / Wiechula, J / Wikne, J / Wilk, G / Wilkinson, J / Willems, G A / Williams, M C S / Willsher, E / Windelband, B / Witt, W E / Yalcin, S / Yamakawa, K / Yang, P / Yano, S / Yin, Z / Yokoyama, H / Yoo, I-K / Yoon, J H / Yurchenko, V / Zaccolo, V / Zaman, A / Zampolli, C / Zanoli, H J C / Zardoshti, N / Zarochentsev, A / Závada, P / Zaviyalov, N / Zbroszczyk, H / Zhalov, M / Zhang, H / Zhang, X / Zhang, Y / Zhang, C / Zhang, Z / Zhao, C / Zhigareva, N / Zhou, D / Zhou, Y / Zhou, Z / Zhu, H / Zhu, J / Zhu, X / Zichichi, A / Zimmermann, A / Zimmermann, M B / Zinovjev, G / Zmeskal, J / Zou, S

    Physical review letters

    2018  Volume 120, Issue 10, Page(s) 102301

    Abstract: The azimuthal anisotropy coefficient v_{2} of prompt D^{0}, D^{+}, D^{*+}, and D_{s}^{+} mesons was measured in midcentral (30%-50% centrality class) Pb-Pb collisions at a center-of-mass energy per nucleon pair sqrt[s_{NN}]=5.02  TeV, with the ALICE ... ...

    Abstract The azimuthal anisotropy coefficient v_{2} of prompt D^{0}, D^{+}, D^{*+}, and D_{s}^{+} mesons was measured in midcentral (30%-50% centrality class) Pb-Pb collisions at a center-of-mass energy per nucleon pair sqrt[s_{NN}]=5.02  TeV, with the ALICE detector at the LHC. The D mesons were reconstructed via their hadronic decays at midrapidity, |y|<0.8, in the transverse momentum interval 1<p_{T}<24  GeV/c. The measured D-meson v_{2} has similar values as that of charged pions. The D_{s}^{+} v_{2}, measured for the first time, is found to be compatible with that of nonstrange D mesons. The measurements are compared with theoretical calculations of charm-quark transport in a hydrodynamically expanding medium and have the potential to constrain medium parameters.<br />
    Language English
    Publishing date 2018-03-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 208853-8
    ISSN 1079-7114 ; 0031-9007
    ISSN (online) 1079-7114
    ISSN 0031-9007
    DOI 10.1103/PhysRevLett.120.102301
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top